Dr. Meador is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305
Summary
- Dr. Kimford Meador is a behavioral neurologist specializing in epilepsy, based in Palo Alto, CA. He completed his medical education at the Medical College of Georgia, followed by a neurology residency at the same institution and a fellowship at the University of Florida. Currently, he is Professor at Stanford University School of Medicine and has been since 2013. Dr. Meador is experienced in various neurological conditions, including epilepsy and cognitive disorders, and has published research on topics such as the cognitive & behavioral effects of epilepsy & its treatments, pregnancy & epilepsy including neurodevelomental effects of antiepileptic drug, and cognitive mechanisms including consciousness. He has conducted multiple clinical trials related to cognitive and developmental effects of epilepsy and its treatments. His work has been recognized with honors such as the CMS Meaningful Use Stage 1 Certification.
Education & Training
- University of FloridaResidency, Neurology, 1983 - 1984
- Medical College of GeorgiaResidency, Neurology, 1980 - 1983
- University of Virginia Medical CenterInternship, Transitional Year, 1976 - 1977
- Medical College of Georgia at Augusta UniversityClass of 1976
Certifications & Licensure
- CA State Medical License 2013 - 2025
- FL State Medical License 2004 - 2025
- GA State Medical License 1977 - 2025
- DC State Medical License 2002 - 2004
- SC State Medical License 1978 - 1987
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy Start of enrollment: 2000 Sep 01
- Study of Antiepileptic Drug Effects on Child Development Start of enrollment: 2002 Sep 01
- Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Author Response: Association of Prenatal Exposure to Antiseizure Medications With Creative and Executive Function at Age 4.5 Years.Kimford J Meador, Morris J Cohen, David W Loring, Abigail G Matthews, Carrie Anne Brown
Neurology. 2025-03-25 - Cognitive function at the time of focal epilepsy diagnosis is not associated with treatment resistance.Jacob Pellinen, Stefan Sillau, Chris Morrison, Paul Maruff, Terence J O'Brien
Epilepsy & Behavior. 2025-02-08 - Prediction of lacosamide concentrations to support dose optimization during pregnancy.Jessica M Barry, Sílvia M Illamola, Page B Pennell, Catherine M Sherwin, Kimford J Meador
Epilepsia. 2025-02-01
Journal Articles
- Changes in Seizure Frequency and Antiepileptic Therapy During PregnancyPage B Pennell, Jacqueline A French, Laura Kalayjian, Patricia Penovich, Evan Gedzelman, Alison M Pack, Kimford J Meador, The New England Journal of Medicine
- Exposure of Infants Who Are Breastfed to Antiepileptic Drugs—ReplyKimford J Meador, Page B Pennell, JAMA Neurology
- Does Memantine Improve Memory in Subjects with Focal-Onset Epilepsy and Memory Dysfunction? A Randomized, Double-Blind, Placebo-Controlled TrialKimford J Meador, Lauren R Moo, Daniel B Hoch, Steven C Schachter, Epilepsy & Behavior
Authored Content
- Exposure of Infants Who Are Breastfed to Antiepileptic Drugs—ReplyAugust 2020
- Long-Term Effects of Adjunctive Perampanel on Cognition in Adolescents with Partial SeizuresJune 2018
Press Mentions
- Reassuring New Data on in Utero Exposure to Antiseizure MedsDecember 5th, 2024
- No Link Between Antiseizure Drugs During Pregnancy, Neurodevelopmental Outcomes in KidsDecember 4th, 2024
- Two Common Antiseizure Medications Do Not Harm Child NeurodevelopmentDecember 4th, 2024
- Join now to see all
Grant Support
- Emory Clinical Research Site For NextNational Institute Of Neurological Disorders And Stroke2011
- Neurodevelopmental Effects Of Antiepileptic Drugs IINational Institute Of Neurological Disorders And Stroke2009
- Neurodevelopmental Effects Of Antiepileptic Drugs IINational Institute Of Neurological Disorders And Stroke2005–2007
- Comparison Of Cognitive, Behavioral Effects Of Levetiracetam, CarbamazepineNational Center For Research Resources2006
- Neurodevelopmental Effects Of Antiepileptic Drugs (Nead Study)National Center For Research Resources2005
- Cognitive &Behavioral Effects Of Levetiracetam &Carbamazepine In Healthy AdultNational Center For Research Resources2005
- Neurodevelopment Effects Of Antiepileptic DrugsNational Institute Of Neurological Disorders And Stroke2004
- Neurodevelopmental Effects Of Antiepileptic Drugs (Nead Study)National Center For Research Resources2004
- Comparison Of The Cognitive And Behavioral Effects Of Levetiracetam And CarbamazNational Center For Research Resources2004
- Neurodevelopment Effects Of Antiepileptic DrugsNational Institute Of Neurological Disorders And Stroke2002–2003
- Neurodevelopment Effects Of Antiepileptic DrugsNational Institute Of Neurological Disorders And Stroke2000–2001
- In Vivo Probe Central Cholinergic SystemsNational Institute On Aging1986–1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: